| Active ingredients | Dosage | Cell line | Tumor types | Pharmacological effects | Ref. |
| Epicatechin Anthocyanin B2 | 102 µg/mL 99 µg/mL | MCF-7 | Breast cancer | potential antitumor activity | [1] |
| Medicated serum | 62 g∙kg−1∙d−1 | S180 | Sarcoma, EAC | reduce tumor weight | [7] |
| 11. 80 g∙kg−1 | HepG2 | Liver cancer | inhibit proliferation | [8] | |
| Water extract | 50 µg/mL 100 µg/mL | CNE-2Z | Nasopharynx cancer | 89.03% inhibition ratio 98.54% inhibition ratio | [11] |
| Ethanol extract | >100 μg/mL | SW480 Colo320 DM | Colorectal carcinoma | suppress cyclins and elevate the Bax/Bcl-2 ratio and caspase 3 activity | [12] |
| Polysaccharide | 50 - 750 μg/mL | HepG2 Hela A549 | Liver cancer Cervical carcinoma Lung adenocarcinoma | Inhibit proliferation | [14] |